Jubilant Life Sciences Q3 net profit at Rs 27 cr due to robust sales

Jubliant Life Sciences

The company's products and services are available in 90 countries as part of its strategic geographic expansion in key markets across business lines, it added.

Shares of Jubilant Life Sciences were today trading at Rs 220 per scrip in the afternoon trade on BSE, up 2.14 per cent from its previous close.

Please read our terms of use before posting comments
TERMS OF USE: The views expressed in comments published on indianexpress.com are those of the comment writer's alone. They do not represent the views or opinions of The Indian Express Group or its staff. Comments are automatically posted live; however, indianexpress.com reserves the right to take it down at any time. We also reserve the right not to publish comments that are abusive, obscene, inflammatory, derogatory or defamatory.